Jpmorgan Chase & CO Cabaletta Bio, Inc. Transaction History

Jpmorgan Chase & CO

$1.23 Trillion
Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 259,392 shares of CABA stock, worth $570,662. This represents 0.0% of its overall portfolio holdings.

Number of Shares

259,392

Previous 279,954 7.34%

Holding current value

$570,662

Previous $1.32 Million 56.85%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$1.87 - $4.91 $38,450 - $100,959	-20,562 Reduced 7.34%	259,392 $570,000
Q3 2024 Dec 26, 2024	SELL	$3.94 - $8.24 $2.67 Million - $5.58 Million	-676,735 Reduced 70.74%	279,954 $1.32 Million
Q3 2024 Nov 08, 2024	SELL	$3.94 - $8.24 $2.67 Million - $5.58 Million	-676,735 Reduced 70.74%	279,954 $1.32 Million
Q2 2024 Dec 26, 2024	BUY	$7.22 - $18.82 $4.89 Million - $12.7 Million	676,735 Added 241.73%	956,689 $7.16 Million
Q2 2024 Aug 12, 2024	BUY	$7.22 - $18.82 $6.74 Million - $17.6 Million	933,034 Added 3944.34%	956,689 $7.16 Million
Q1 2024 Dec 26, 2024	SELL	$16.79 - $25.38 $4.3 Million - $6.5 Million	-256,299 Reduced 91.55%	23,655 $403,000
Q1 2024 May 10, 2024	SELL	$16.79 - $25.38 $355,696 - $537,675	-21,185 Reduced 47.25%	23,655 $403,000
Q4 2023 Dec 26, 2024	SELL	$12.21 - $23.36 $2.87 Million - $5.49 Million	-235,114 Reduced 83.98%	44,840 $1.02 Million
Q4 2023 Feb 12, 2024	BUY	$12.21 - $23.36 $258,510 - $494,577	21,172 Added 89.45%	44,840 $1.02 Million
Q3 2023 Nov 14, 2023	BUY	$11.84 - $18.65 $37,935 - $59,754	3,204 Added 15.66%	23,668 $360,000
Q2 2023 Aug 11, 2023	BUY	$7.65 - $13.95 $151,707 - $276,642	19,831 Added 3132.86%	20,464 $264,000
Q4 2022 Feb 13, 2023	SELL	$0.64 - $9.3 $816 - $11,866	-1,276 Reduced 66.84%	633 $6,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $2.05 $195 - $637	311 Added 19.46%	1,909 $1,000
Q2 2022 Aug 11, 2022	SELL	$0.99 - $2.11 $2,088 - $4,452	-2,110 Reduced 56.9%	1,598 $2,000
Q1 2022 May 11, 2022	BUY	$1.68 - $3.92 $1,426 - $3,328	849 Added 29.7%	3,708 $8,000
Q4 2021 Feb 10, 2022	SELL	$3.36 - $14.64 $51,562 - $224,665	-15,346 Reduced 84.3%	2,859 $11,000
Q3 2021 Nov 12, 2021	BUY	$7.0 - $12.5 $127,435 - $227,562	18,205 New	18,205 $221,000

Others Institutions Holding CABA

# of Institutions

115

Shares Held

39.6M

Call Options Held

297K

Put Options Held

98.6K

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $63.8M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Cabaletta Bio, Inc. Transaction History